HI
MRTX

Hoey Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Hoey Investments’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-350
Closed -$20.6K – 380
2023
Q4 		$20.6K Hold
350
– – 0.01% 169
2023
Q3 		$15.2K Hold
350
– – 0.01% 183
2023
Q2 		$12.6K Buy
+350
New +$14.4K ﹤0.01% 198

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hoey Investments's MRTX Position: Q1 2024 in Review

Hoey Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 350 shares — an estimated $20.6K sold.

Hoey Investments first reported a position in MRTX in Q2 2023 and held it in 3 quarters. The position peaked at $20.6K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Hoey Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Hoey Investments sold 350 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $20.6K.
  • Hoey Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Hoey Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $20.6K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Hoey Investments's 13F filing for Q1 2024, filed 10 May 2024.